Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

NCT05826275 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV Associated Cancers

Interventions

DRUG: TGN-S11
DRUG: Pembrolizumab

Sponsor

Toragen, Inc.